Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
Penumbra(US:PEN) Prnewswire·2025-10-27 21:00Accessibility StatementSkip Navigation ALAMEDA, Calif., Oct. 27, 2025 /PRNewswire/ --Â Penumbra, Inc. (NYSE: PEN) announced the results of the landmark STORM-PE randomized controlled trial (RCT), which found that the use of mechanical thrombectomy, specifically computer assisted vacuum thrombectomy (CAVTâ"¢), with anticoagulation achieved superior reduction in right heart strain compared to nticoagulation therapy alone in patients with acute intermediate-high risk pulmonary embolism (PE). The data was prese ...